» Articles » PMID: 24811256

Prognostic Value of the Lymph Node Ratio in Stage III Gastric Cancer Patients Undergoing Radical Resection

Overview
Journal PLoS One
Date 2014 May 10
PMID 24811256
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: The aim of this study was to investigate the prognostic value of metastatic lymph node ratio (LNR) in patients having radical resection for stage III gastric cancer.

Methods: A total of 365 patients with stage III gastric cancer who underwent radical resection between 2002 and 2008 at Tianjin Medical University Cancer Institute and Hospital were analyzed. The cut-point survival analysis was adopted to determine the appropriate cutoffs for LNR. Kaplan-Meier survival curves and log-rank tests were used for the survival analysis.

Results: By cut-point survival analysis, the LNR staging system was generated using 0.25 and 0.50 as the cutoff values. Pearson's correlation test revealed that the LNR was related with metastatic lymph nodes but not related with total harvested lymph nodes. Cox regression analysis showed that depth of invasion and LNR were the independent predictors of survival (p<0.05). There was a significant difference in survival between each pN stages classified by the LNR staging, however no significant difference was found in survival rate between each LNR stages classified by the pN staging.

Conclusions: The LNR is an independent prognostic factor for survival in stage III gastric cancer and is superior to the pN category in TNM staging. It may be considered as a prognostic variable in future staging system.

Citing Articles

Prognostic significance of lymph node ratio in esophageal squamous cell carcinoma: insights from the South Asian population.

Qureshi S, Abbasi W, Jalil H, Mughal S, Quraishy M Front Oncol. 2025; 14:1430876.

PMID: 39896181 PMC: 11784524. DOI: 10.3389/fonc.2024.1430876.


Evaluation of Four Lymph Node Classifications for the Prediction of Survival in Hilar Cholangiocarcinoma.

Liu Z, Zhang Q, Chen W, Huang Y, Zhang Y, Gong Y J Gastrointest Surg. 2022; 26(5):1030-1040.

PMID: 34973138 PMC: 9085675. DOI: 10.1007/s11605-021-05211-x.


Metastatic Lymph Node Ratio for Predicting Recurrence in Medullary Thyroid Cancer.

Kim J, Park J, Park H, Choi M, Jang H, Kim T Cancers (Basel). 2021; 13(22).

PMID: 34830996 PMC: 8616059. DOI: 10.3390/cancers13225842.


Value of the log odds of positive lymph nodes for prognostic assessment of colon mucinous adenocarcinoma: Analysis and external validation.

Cai H, Xu T, Zhuang Z, Zhang Y, Gao Y, Liu X Cancer Med. 2021; 10(23):8542-8557.

PMID: 34796687 PMC: 8633225. DOI: 10.1002/cam4.4366.


Prognostic Significance of Metastatic Lymph Nodes Ratio (MLNR) Combined with Protein-Tyrosine Phosphatase H1 (PTPH1) Expression in Operable Breast Invasive Ductal Carcinoma.

Ma S, Lv Y, Ma R Cancer Manag Res. 2020; 12:1895-1901.

PMID: 32214847 PMC: 7078764. DOI: 10.2147/CMAR.S239085.


References
1.
Nakajima T . Gastric cancer treatment guidelines in Japan. Gastric Cancer. 2002; 5(1):1-5. DOI: 10.1007/s101200200000. View

2.
Pedrazzani C, Sivins A, Ancans G, Marrelli D, Corso G, Krumins V . Ratio between metastatic and examined lymph nodes (N ratio) may have low clinical utility in gastric cancer patients treated by limited lymphadenectomy: results from a single-center experience of 526 patients. World J Surg. 2009; 34(1):85-91. DOI: 10.1007/s00268-009-0288-8. View

3.
Ueno S, Tanabe G, Sako K, Hiwaki T, Hokotate H, Fukukura Y . Discrimination value of the new western prognostic system (CLIP score) for hepatocellular carcinoma in 662 Japanese patients. Cancer of the Liver Italian Program. Hepatology. 2001; 34(3):529-34. DOI: 10.1053/jhep.2001.27219. View

4.
Sun Z, Wang Z, Zhu Z, Xu Y, Xu Y, Huang B . Evaluation of the seventh edition of American Joint Committee on Cancer TNM staging system for gastric cancer: results from a Chinese monoinstitutional study. Ann Surg Oncol. 2012; 19(6):1918-27. DOI: 10.1245/s10434-011-2206-1. View

5.
Lee S, Kim H, Son B, Shin J, Yoo C . Prognostic significance of the metastatic lymph node ratio in patients with gastric cancer. World J Surg. 2012; 36(5):1096-1101. DOI: 10.1007/s00268-012-1520-5. View